Having trouble accessing articles? Reset your cache.

Avastin bevacizumab: Development discontinued

Roche said it discontinued development of Avastin for adjuvant colorectal cancer after it missed the primary endpoints in 2 previously

Read the full 206 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE